Our stories

Every day, we’re guided by our purpose
to use the power of leading-edge science
to save and improve lives around the world.

Filter by:

All

Our People

Patients

Health awareness

Sustainability

Innovation

Arrow right icon
Understanding blood cancers
Innovation

Understanding blood cancers

How MSD is helping advance research with new approaches for people living with these challenging conditions

MSD’s One Pipeline strategy: Purpose, patients and big bets on science
Innovation

MSD’s One Pipeline strategy: Purpose, patients and big bets on science

Our approach to drug development aims to bring together our own innovation with the best external science so we can more quickly help patients who are counting on us

What are individualized neoantigen therapies?
Innovation

What are individualized neoantigen therapies?

How scientists are harnessing the specific mutations of each person’s cancer to evaluate therapies that would be tailored to their own tumor

MSD and City Cancer Challenge expand global partnership to strengthen women’s cancer care
Sustainability

MSD and City Cancer Challenge expand global partnership to strengthen women’s cancer care

This initiative aims to reach more than 300,000 women living with cancer around the world by 2030

MSD for Mothers: Expanding access to quality maternal care
Sustainability

MSD for Mothers: Expanding access to quality maternal care

More than a decade of strategic partnerships, private sector innovation and data-driven impact to help create a world where no woman has to die while giving life

Know your risk for bladder cancer — and don’t ignore the signs
Health awareness

Know your risk for bladder cancer — and don’t ignore the signs

Awareness gaps can impact recognition and diagnosis of bladder cancer

Immunology Q&A: Experts discuss how science is advancing disease research
Innovation

Immunology Q&A: Experts discuss how science is advancing disease research

MSD R&D teams are exploring how emerging therapies and precision medicine are shaping the future of immune-mediated disease research

Loading stories…